SIGA Pharmaceuticals, Inc.
11Patents
0Active
11Granted
29Portfolio score
Filing activity: Jun 5, 1995 → Mar 7, 2001
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5821088A | Use of gram-positive bacteria to express recombinant proteins | Chemistry; Metallurgy | 56 | Expired |
| US6153396A | Treatment or prophylaxis of diseases caused by pilus-forming bacteria | Emerging Cross-Sectional Technologies | 53 | Expired |
| US6962791B2 | Treatment or prophylaxis of diseases caused by pilus-forming bacteria | Emerging Cross-Sectional Technologies | 50 | Expired |
| US6872542B1 | Treatment or prophylaxis of diseases caused by pilus-forming bacteria | Physics | 46 | Expired |
| US6420127B1 | Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections | Emerging Cross-Sectional Technologies | 41 | Expired |
| US5976792A | Regulation of exoprotein in staphylococcus aureus | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6306619A | DegP periplasmic protease a new anti-infective target and an in vitro assay for DegP protease function | Physics | 15 | Expired |
| US6548265B2 | Treatment or prophylaxis of diseases caused by pilus-forming bacteria | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6596504B2 | Treatment of prophylaxis of diseases caused by pilus-forming bacteria | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6312955A | Streptococcus gordonii strains resistant to fluorodeoxyuridine | Chemistry; Metallurgy | 0 | Expired |
| US7025971B2 | Treatment or prophylaxis of diseases caused by pilus-forming bacteria | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.